GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kimia Biosciences Ltd

Kimia Biosciences Q2 FY27 Net Profit Rs. 35.58 Lakhs

RESULTS ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 13 Nov 2026, 04:59 PM IST  ·  BSE ID: bae2cb01-a65d-47d5-9df9-411b488a6a91
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its financial results for the second quarter and first half of the current fiscal year.
🤖 AI Summary
  • Kimia Biosciences reported Q2 FY27 revenue from operations of Rs. 2,072.25 Lakhs for the quarter ended September 30, 2026.
  • Net Profit for the second quarter (Q2 FY27) stood at Rs. 35.58 Lakhs.
  • Half-year revenue from operations (April 1, 2026 to September 30, 2026) was Rs. 4,753.44 Lakhs.
  • Half-year net profit for FY27 (April 1, 2026 to September 30, 2026) was Rs. 271.43 Lakhs.
  • The Statutory Auditors' Limited Review Report on the results was with an unmodified opinion.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
2,072.25 Lakhs
-39.19%
Net Profit (Q2 FY27)
35.58 Lakhs
-27.20%
Total Income (Q2 FY27)
2,080.31 Lakhs
-39.54%
Total Expenses (Q2 FY27)
2,036.31 Lakhs
-36.72%
Basic EPS (Q2 FY27)
0.08
-60.00%
Revenue from Operations (Half Year FY27)
4,753.44 Lakhs
-16.07%
Net Profit (Half Year FY27)
271.43 Lakhs
65.36%
🏢 How This Affects the Company
💰
Financial Impact
The company recorded a Net Profit of Rs. 35.58 Lakhs for Q2 FY27, an increase from Rs. 48.98 Lakhs in the prior comparable quarter. Half-year Net Profit was Rs. 271.43 Lakhs, up from Rs. 164.14 Lakhs in the prior half-year.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as these results provide an update on the company's financial performance, showing a rise in net profit despite a dip in quarterly revenue.
🔍
Management Signal
The financial results indicate management's focus on profitability, evidenced by increased net profit margins even with lower quarterly revenue.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — assess revenue stabilization and profit consistency.
Next Board Meeting outcome — check for operational or strategic updates.
Investor call transcripts — gain insights into management's outlook and strategy.
MEDIUM RISK Significant year-on-year decline in quarterly revenue, partially offset by increased half-year net profit.
💡 Investor Takeaway
Kimia Biosciences reported Q2 FY27 Net Profit of Rs. 35.58 Lakhs, compared to Rs. 48.98 Lakhs in Q2 FY26. Revenue from operations for the quarter decreased to Rs. 2,072.25 Lakhs from Rs. 3,399.93 Lakhs year-on-year. Half-year net profit for FY27 was Rs. 271.43 Lakhs, up from Rs. 164.14 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Net Profit for Q2 FY27 increased to Rs. 35.58 Lakhs from Rs. 48.98 Lakhs in Q2 FY26.
  • Half-year Net Profit for FY27 significantly rose to Rs. 271.43 Lakhs compared to Rs. 164.14 Lakhs in the corresponding period of FY26.

⚠️ Concerns

  • Revenue from Operations for Q2 FY27 decreased to Rs. 2,072.25 Lakhs from Rs. 3,399.93 Lakhs in Q2 FY26.
  • Total Expenses for Q2 FY27 reduced to Rs. 2,036.31 Lakhs from Rs. 3,217.76 Lakhs in Q2 FY26.
📅 Company Track Record
Kimia Biosciences reported Q1 FY27 un-audited results in August 2026. For the full year ended March 31, 2026 (FY26), the company reported a Net Profit of Rs. 1,991.70 Lacs.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Kimia Biosciences' net profit in Q2 FY27?
Kimia Biosciences reported a Net Profit of Rs. 35.58 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was Kimia Biosciences' revenue from operations in Q2 FY27?
The company's Revenue from Operations for Q2 FY27 was Rs. 2,072.25 Lakhs.
What was Kimia Biosciences' half-year net profit for FY27?
For the half year ended September 30, 2026 (FY27), Kimia Biosciences' Net Profit was Rs. 271.43 Lakhs.
When were the Q2 FY27 results of Kimia Biosciences approved?
The Unaudited Standalone Financial Results for Q2 FY27 were approved by the Board of Directors on November 13, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel